NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Buy
63
COO Quote, Financials, Valuation and Earnings
Last price:
$92.52
Seasonality move
:
10.1%
Day range:
$92.28 - $94.71
52-week range:
$84.76 - $112.38
Dividend yield:
0%
P/E ratio:
47.92x
P/S ratio:
4.81x
P/B ratio:
2.31x
Volume:
2.6M
Avg. volume:
1.6M
1-year change:
3.72%
Market cap:
$18.6B
Revenue:
$3.9B
EPS (TTM):
$1.95
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$1B | $1.00 | 5.02% | 122.62% | $112.01 |
|
GMED
Globus Medical
|
$604.8M | $0.65 | 3.07% | 577.27% | $94.23 |
|
KIDS
OrthoPediatrics
|
$53.7M | -$0.19 | 34.88% | -11.49% | $40.17 |
|
LUCY
Innovative Eyewear
|
$900K | -$1.36 | 62.4% | -78.2% | -- |
|
NXGL
NexGel
|
$2.8M | -$0.14 | 195.01% | -20% | -- |
|
STAA
Staar Surgical
|
$86.9M | $0.17 | 2.4% | -49.22% | $41.89 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$93.44 | $112.01 | $18.6B | 47.92x | $0.01 | 0% | 4.81x |
|
GMED
Globus Medical
|
$82.63 | $94.23 | $11.3B | 123.33x | $0.00 | 0% | 4.57x |
|
KIDS
OrthoPediatrics
|
$22.39 | $40.17 | $542.2M | -- | $0.00 | 0% | 2.71x |
|
LUCY
Innovative Eyewear
|
$5.70 | -- | $13.9M | -- | $0.00 | 0% | 3.72x |
|
NXGL
NexGel
|
$4.73 | -- | $32.1M | -- | $0.00 | 0% | 4.31x |
|
STAA
Staar Surgical
|
$24.82 | $41.89 | $1.2B | 56.41x | $0.00 | 0% | 3.59x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COO
The Cooper Companies
|
24.2% | 1.416 | 12.35% | 0.81x |
|
GMED
Globus Medical
|
9.7% | 2.476 | 4.5% | 1.57x |
|
KIDS
OrthoPediatrics
|
16.38% | 0.435 | 11.07% | 3.43x |
|
LUCY
Innovative Eyewear
|
-- | 9.717 | -- | 14.63x |
|
NXGL
NexGel
|
18.36% | 1.704 | 5.91% | 0.64x |
|
STAA
Staar Surgical
|
-- | 0.076 | -- | 5.18x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COO
The Cooper Companies
|
$677.7M | $198.4M | 3.75% | 5.02% | 19.21% | $128.1M |
|
GMED
Globus Medical
|
$355.2M | $49M | 2.05% | 2.27% | 7.83% | $161.7M |
|
KIDS
OrthoPediatrics
|
$40.1M | -$5.6M | -7.23% | -7.63% | -16% | -$11.7M |
|
LUCY
Innovative Eyewear
|
$59.3K | -$1.8M | -113.55% | -113.55% | -678.5% | -$1.5M |
|
NXGL
NexGel
|
$1.3M | -$788K | -59.05% | -67.5% | -24.97% | -$1.2M |
|
STAA
Staar Surgical
|
$68.5M | $5.7M | 5.46% | 5.46% | 6.41% | -$2.4M |
The Cooper Companies vs. Competitors
-
Which has Higher Returns COO or GMED?
Globus Medical has a net margin of 11.54% compared to The Cooper Companies's net margin of 8.28%. The Cooper Companies's return on equity of 5.02% beat Globus Medical's return on equity of 2.27%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B GMEDGlobus Medical56.77% $0.38 $4.5B -
What do Analysts Say About COO or GMED?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 19.87%. On the other hand Globus Medical has an analysts' consensus of $94.23 which suggests that it could grow by 14.04%. Given that The Cooper Companies has higher upside potential than Globus Medical, analysts believe The Cooper Companies is more attractive than Globus Medical.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 GMEDGlobus Medical5 4 0 -
Is COO or GMED More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison Globus Medical has a beta of 1.190, suggesting its more volatile than the S&P 500 by 19.035%.
-
Which is a Better Dividend Stock COO or GMED?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Globus Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Globus Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or GMED?
The Cooper Companies quarterly revenues are $1B, which are larger than Globus Medical quarterly revenues of $625.7M. The Cooper Companies's net income of $117.5M is higher than Globus Medical's net income of $51.8M. Notably, The Cooper Companies's price-to-earnings ratio is 47.92x while Globus Medical's PE ratio is 123.33x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.81x versus 4.57x for Globus Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.81x 47.92x $1B $117.5M GMEDGlobus Medical4.57x 123.33x $625.7M $51.8M
-
Which has Higher Returns COO or KIDS?
OrthoPediatrics has a net margin of 11.54% compared to The Cooper Companies's net margin of -14.51%. The Cooper Companies's return on equity of 5.02% beat OrthoPediatrics's return on equity of -7.63%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B KIDSOrthoPediatrics73.41% -$0.34 $443.6M -
What do Analysts Say About COO or KIDS?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 19.87%. On the other hand OrthoPediatrics has an analysts' consensus of $40.17 which suggests that it could grow by 79.4%. Given that OrthoPediatrics has higher upside potential than The Cooper Companies, analysts believe OrthoPediatrics is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 KIDSOrthoPediatrics2 1 0 -
Is COO or KIDS More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison OrthoPediatrics has a beta of 1.143, suggesting its more volatile than the S&P 500 by 14.295%.
-
Which is a Better Dividend Stock COO or KIDS?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. OrthoPediatrics pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or KIDS?
The Cooper Companies quarterly revenues are $1B, which are larger than OrthoPediatrics quarterly revenues of $54.6M. The Cooper Companies's net income of $117.5M is higher than OrthoPediatrics's net income of -$7.9M. Notably, The Cooper Companies's price-to-earnings ratio is 47.92x while OrthoPediatrics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.81x versus 2.71x for OrthoPediatrics. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.81x 47.92x $1B $117.5M KIDSOrthoPediatrics2.71x -- $54.6M -$7.9M
-
Which has Higher Returns COO or LUCY?
Innovative Eyewear has a net margin of 11.54% compared to The Cooper Companies's net margin of -678.5%. The Cooper Companies's return on equity of 5.02% beat Innovative Eyewear's return on equity of -113.55%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B LUCYInnovative Eyewear23.4% -$0.99 $10.9M -
What do Analysts Say About COO or LUCY?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 19.87%. On the other hand Innovative Eyewear has an analysts' consensus of -- which suggests that it could grow by 145.61%. Given that Innovative Eyewear has higher upside potential than The Cooper Companies, analysts believe Innovative Eyewear is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 LUCYInnovative Eyewear0 0 0 -
Is COO or LUCY More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison Innovative Eyewear has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or LUCY?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Innovative Eyewear pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or LUCY?
The Cooper Companies quarterly revenues are $1B, which are larger than Innovative Eyewear quarterly revenues of $253.6K. The Cooper Companies's net income of $117.5M is higher than Innovative Eyewear's net income of -$1.7M. Notably, The Cooper Companies's price-to-earnings ratio is 47.92x while Innovative Eyewear's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.81x versus 3.72x for Innovative Eyewear. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.81x 47.92x $1B $117.5M LUCYInnovative Eyewear3.72x -- $253.6K -$1.7M
-
Which has Higher Returns COO or NXGL?
NexGel has a net margin of 11.54% compared to The Cooper Companies's net margin of -23.57%. The Cooper Companies's return on equity of 5.02% beat NexGel's return on equity of -67.5%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B NXGLNexGel43.61% -$0.11 $6M -
What do Analysts Say About COO or NXGL?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 19.87%. On the other hand NexGel has an analysts' consensus of -- which suggests that it could grow by 26.85%. Given that NexGel has higher upside potential than The Cooper Companies, analysts believe NexGel is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 NXGLNexGel0 0 0 -
Is COO or NXGL More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison NexGel has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or NXGL?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. NexGel pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or NXGL?
The Cooper Companies quarterly revenues are $1B, which are larger than NexGel quarterly revenues of $2.9M. The Cooper Companies's net income of $117.5M is higher than NexGel's net income of -$693K. Notably, The Cooper Companies's price-to-earnings ratio is 47.92x while NexGel's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.81x versus 4.31x for NexGel. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.81x 47.92x $1B $117.5M NXGLNexGel4.31x -- $2.9M -$693K
-
Which has Higher Returns COO or STAA?
Staar Surgical has a net margin of 11.54% compared to The Cooper Companies's net margin of 11.27%. The Cooper Companies's return on equity of 5.02% beat Staar Surgical's return on equity of 5.46%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Companies66.55% $0.58 $10.7B STAAStaar Surgical77.31% $0.20 $428.1M -
What do Analysts Say About COO or STAA?
The Cooper Companies has a consensus price target of $112.01, signalling upside risk potential of 19.87%. On the other hand Staar Surgical has an analysts' consensus of $41.89 which suggests that it could grow by 68.76%. Given that Staar Surgical has higher upside potential than The Cooper Companies, analysts believe Staar Surgical is more attractive than The Cooper Companies.
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Companies9 7 0 STAAStaar Surgical7 5 1 -
Is COO or STAA More Risky?
The Cooper Companies has a beta of 0.968, which suggesting that the stock is 3.236% less volatile than S&P 500. In comparison Staar Surgical has a beta of 0.587, suggesting its less volatile than the S&P 500 by 41.304%.
-
Which is a Better Dividend Stock COO or STAA?
The Cooper Companies has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Staar Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Companies pays -- of its earnings as a dividend. Staar Surgical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or STAA?
The Cooper Companies quarterly revenues are $1B, which are larger than Staar Surgical quarterly revenues of $88.6M. The Cooper Companies's net income of $117.5M is higher than Staar Surgical's net income of $10M. Notably, The Cooper Companies's price-to-earnings ratio is 47.92x while Staar Surgical's PE ratio is 56.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Companies is 4.81x versus 3.59x for Staar Surgical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Companies4.81x 47.92x $1B $117.5M STAAStaar Surgical3.59x 56.41x $88.6M $10M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 1.23% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 4.25% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.65% over the past day.
